T1	Participants 139 146	animals
T2	Participants 474 545	57 consecutive patients with primary ureteropelvic junction obstruction
T3	Participants 712 720	patients
T4	Participants 885 896	26 patients
T5	Participants 932 956	2 groups were comparable
T6	Participants 1159 1177	24 group 1 (92.3%)
T7	Participants 1182 1200	23 group 2 (90.3%)
T8	Participants 1341 1367	patients in groups 1 and 2
T9	Participants 1491 1507	group 2 patients
